ATX Announcement
FAK INHIBITORS REDUCE FIBROSIS OF NASH AMP945 produces a statistically significant reduction in liver fibrosis
- Forums
- ASX - Day Trading
- Day trading pre-market open April 20
ATX Announcement FAK INHIBITORS REDUCE FIBROSIS OF NASH AMP945...
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online